ROKIT Healthcare Inc. (KOSDAQ:376900)
South Korea flag South Korea · Delayed Price · Currency is KRW
27,600
0.00 (0.00%)
At close: Sep 9, 2026

ROKIT Healthcare Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
32,81426,24713,11112,4189,1516,741
Other Revenue
-0-0-0-0-0-
32,81426,24713,11112,4189,1516,741
Revenue Growth
106.19%100.19%5.59%35.70%35.76%68.94%
Cost of Revenue
16,88810,5777,1478,3916,0875,126
Gross Profit
15,92615,6705,9644,0263,0641,615
Selling, General & Admin
22,81412,9948,2178,35312,74713,661
Research & Development
3,6391,0231,5711,7722,9793,825
Amortization of Goodwill & Intangibles
246.64315.64304.26465.35433.47448.22
Other Operating Expenses
116.0242.131.0346.034651.68
Operating Expenses
31,31915,63412,00611,59416,93818,935
Operating Income
-15,39335.58-6,042-7,568-13,873-17,320
Interest Expense
-4,826-4,570-6,845-6,209-4,503-3,290
Interest & Investment Income
554.41380.6751.6450.5730.0829.52
Earnings From Equity Investments
-10.58-2.99----
Currency Exchange Gain (Loss)
483.229.85-53.5619.1321.99285.9
Other Non Operating Income (Expenses)
6,9412,1825,53331,21820,353-35,526
EBT Excluding Unusual Items
-12,252-1,965-7,35617,5112,029-55,820
Gain (Loss) on Sale of Investments
399.17-----
Gain (Loss) on Sale of Assets
0.860.860.99-2.29-1.80.36
Asset Writedown
45.4844.2918.28-687.74--464.33
Other Unusual Items
---10.11--
Pretax Income
-11,807-1,920-7,33716,8312,027-56,284
Income Tax Expense
885.21885.21352.74204.02169.59108.86
Earnings From Continuing Operations
-12,692-2,805-7,69016,6271,857-56,393
Minority Interest in Earnings
2.15-40.4644.34-27.1717.39145.59
Net Income
-12,690-2,845-7,64616,6001,875-56,247
Net Income to Common
-12,690-2,845-7,64616,6001,875-56,247
Net Income Growth
---785.55%--
Shares Outstanding (Basic)
16138777
Shares Outstanding (Diluted)
1613812127
Shares Change
73.10%64.22%-34.20%0.64%72.42%6.78%
EPS (Basic)
-812.62-221.69-978.302324.34267.01-8217.71
EPS (Diluted)
-812.87-222.00-978.30-829.59-1232.84-8218.00
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-26,183-17,393-5,023-4,065-6,777-12,121
Free Cash Flow Per Share
-1676.69-1355.21-642.68-342.24-574.26-1770.81
Gross Margin
48.54%59.70%45.49%32.42%33.49%23.96%
Operating Margin
-46.91%0.14%-46.09%-60.94%-151.61%-256.95%
Profit Margin
-38.67%-10.84%-58.31%133.68%20.48%-834.44%
Free Cash Flow Margin
-79.79%-66.27%-38.31%-32.73%-74.06%-179.81%
EBITDA
-14,621835.61-5,054-6,300-12,498-15,712
EBITDA Margin
-44.56%3.18%-38.55%-50.73%-136.57%-233.08%
D&A For EBITDA
772.45800.03987.81,2671,3761,609
EBIT
-15,39335.58-6,042-7,568-13,873-17,320
EBIT Margin
-46.91%0.14%-46.08%-60.94%-151.61%-256.95%
Effective Tax Rate
---1.21%8.37%-
Advertising Expenses
-1,875430.02303.4752.62647.84